% | $
Quotes you view appear here for quick access.

Sunesis Pharmaceuticals, Inc. Message Board

  • marko29911 marko29911 Jul 29, 2013 4:25 PM Flag

    DEMC recommends to discontinue SNSS Cardiff study enrollment

    SNSS was due to report earnings and an update on August 5th but supposed with an early release today. The news was not good, as the DEMC has recommend that enrollment in the SNSS Cardiff university be discontinued. This is not good news for a company that only has a single drug to offer and the stock will no doubt tank badly at the open tomorrow, likely down to the $4.25 - $4.50 next support level -- and with no other real positive catalyst until 2014, it could bottom even lower. Ouch!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.02-0.02(-0.50%)11:46 AMEDT